Imagenetix, Inc. (IAGX) Research

Established in 1996 and headquartered in San Diego, California, Imagenetix, Inc. focuses on the creation, manufacturing, and distribution of distinctive, natural-ingredient nutritional supplements, as well as non-prescription topical creams and skincare solutions. Its flagship product, Celadrin, is a specialized formulation aimed at promoting joint well-being. The company also extends its business by licensing its proprietary technologies to third parties. Imagenetix reaches its customer base through a wide range of marketing avenues, encompassing direct and large-scale marketing enterprises, health and nutritional periodicals, medical and wellness professionals, and direct-response campaigns across radio and television.

Market snapshot

Symbol
IAGX
Price
$0.00
Day change
0.00%
Market cap
$2.8K
P/E ratio
-0.13x
52-week range
0.0001-0.0001
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Peer companies

  • BZAM Ltd. (BZAMF)
  • CanaQuest Medical Corp. (CANQF)
  • Ventura Cannabis & Wellness Corporation (CVHIF)
  • GlobeImmune, Inc. (GBIM)
  • New Leaf Ventures Inc (NLVVF)
  • Neurobiological Technologies, Inc. (NTII)
  • Quick-Med Technologies, Inc. (QMDT)
  • Anbc, Inc. (SYUP)

Open Imagenetix, Inc. (IAGX) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.